[1]白艳霞,牛艳玲,刘 倩,等.陕西榆林地区青年胃癌内镜下表现及临床病理特征研究[J].陕西医学杂志,2024,(9):1269-1271,1277.[doi:DOI:10.3969/j.issn.1000-7377.2024.09.025]
点击复制

陕西榆林地区青年胃癌内镜下表现及临床病理特征研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年9期
页码:
1269-1271,1277
栏目:
临床病理
出版日期:
2024-09-05

文章信息/Info

作者:
白艳霞; 牛艳玲; 刘 倩; 冯 艳; 刘小玉
(西安交通大学第一附属医院榆林医院,陕西 榆林 719000)
关键词:
青年胃癌;  幽门螺杆菌感染;  内镜表现;  病理特征;  临床表现;  榆林地区
分类号:
R 735.2
DOI:
DOI:10.3969/j.issn.1000-7377.2024.09.025
文献标志码:
A
摘要:
目的:探讨陕西省榆林地区青年胃癌内镜下表现及临床病理特征。方法:回顾性收集青年胃癌患者76例,记录一般资料、幽门螺杆菌感染(HP)情况、临床特点、内镜表现、病理特征等情况,并分析数据。结果:76例青年胃癌患者中,男性37例,女性39例,男女比例为1:1.05; 年龄16～40岁,平均(33.58±4.89)岁; 肿瘤部位主要见于全胃下1/3,占比57.89%,以胃窦为主; 临床表现以腹痛和腹胀最为常见,分别为26例(34.21%)和31例(40.78%); HP阳性58例(76.32%),HP阴性18例(23.68%)。内镜下,早期胃癌1例(1.32%),进展期胃癌75例(98.68%)。进展期胃癌Borrmann Ⅰ型4例(5.26%),Ⅱ型24(31.58%),Ⅲ型44(57.90%)、Ⅳ型4例(5.26%)。病理分型中,印戒细胞癌17例(22.37%),管状腺癌55例(72.37%)、黏液腺癌4例(5.26%)。管状腺癌中,低、中、高分化分别为29例、20例和6例,占比依次为38.16%、26.32%和7.89%。青年胃癌以管状腺癌、印戒细胞癌为主,其中管状腺癌以低、中分化为主,恶性程度高,呈侵袭性生长,易向周围组织转移,早期发现率低,患者生存率低。结论:陕西省榆林地区青年胃癌具有女性患者略多,症状隐匿,病变范围大,呈侵袭性生长,恶性程度高,分化差,病程短及误诊、漏诊率高等特征。

参考文献/References:

[1] SUNG H,FERLAY J,SIEGEL R L,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] CHEN W,SUN K,ZHENG R,et al.Cancer incidence and mortality in China,2014[J].Chinese Journal of Cancer Research,2018,30(1):1-12.
[3] 刘小玉,牛艳玲,白艳霞,等.榆林地区农村居民胃癌流行病学分析[J].中国血液流变学杂志,2020,30(4):462-466.
[4] MILLER K D,FIDLER-BENAOUDIA M,KEEGAN T H,et al.Cancer statistics for adolescents and young adults,2020[J].CA Cancer J Clin,2020,70(6):443-459.
[5] WANG S,DONG D,ZHANG W,et al.Specific borrmann classification in advanced gastric cancer by an ensemble multilayer perceptron network:A multicenter research[J].Med Phys,2021,48(9):5017-5028.
[6] 国家“863”重大项目“胃癌分子分型与个体化诊疗”课题组.胃癌病理分型和诊断标准的建议[J].中华病理学杂志,2010,39(4):266-269.
[7] DISEASES G B D,INJURIES C.Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:A systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[8] YANG W J,ZHAO H P,YU Y,et al.Updates on global epidemiology,risk and prognostic factors of gastric cancer[J].World J Gastroenterol,2023,29(16):2452-2468.
[9] 沈家林,许雨晴,曹若彤,等.金果胃康胶囊对胃癌前病变模型大鼠胃黏膜ULK1/AMPK/mTOR信号通路的影响[J].陕西中医,2024,45(4):446-450.
[10] 朱晶,王琦苑,钱蓉,等.消痰散结方联合卡培他滨治疗晚期胃癌临床研究[J].陕西中医,2024,45(2):191-195.
[11] 宋健,孟凯强,雷根平,等.名中医沈舒文使用动物类中药治疗胃癌前病变临床经验[J].陕西中医,2024,45(2):256-259.
[12] 刘颖初,汪红兵,王雅欣,等.基于“补气活血”理论探讨胃癌前病变的“炎癌转化”[J].陕西中医,2023,44(12):1767-1770.
[13] XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022:Profiles,trends,and determinants[J].Chin Med J(Engl),2022,135(5):584-590.
[14] YAO Q,QI X,XIE S H.Sex diference in the incidence of cardia and non-cardia gastric cancer in the United States,1992—2014[J].BMC Gastroenterol,2020,20(1):418-425.
[15] HALLINAN J T,VENKATESH S K,PETER L,et al.CT volumetry for gastric carcinoma:Association with TNM stage[J].Eur Radiol,2014,24(12):3105-3114.
[16] KASASHIMA H,YASHIRO M,NAKAMAE H,et al.Bone marrow-derived stromal oells are associated with gastric cancer pmogression[J].Br J Cancer,2015,113(3):443-452.
[17] LI J,KUANG XH,ZHANG Y,et al.Global burden of gastric cancer in adolescents and young adults:Estimates from GLOBOCAN 2020[J].Public Health,2022,210:58-64.
[18] 牛鹏辉.青年胃癌的临床病理及分子特征研究[D].北京:北京协和医学院,2023.
[19] WANG Z,XU J,ZHENG S,et al.Clinicopathologic characteristics and prognostic of gastric cancer in young patients[J].Scand J Gastroenterol,2016,51(9):1043-1049.
[20] LI I,NI J,SUN S,et a1.Clinical applicahility of a new scoring system for population based screening and risk factors of gastric cancer in the Wannan region[J].BMC Gastroenterol.2022,22(1):306.
[21] JING Y,XU F,LIANG W,et a1.Role of regulatory B ceils in gastric cancer:Latest evidence and therapeutics strategies[J].Int hmnunopharmacol,2021,96(2):107581.
[22] BARTPHO T S,WATTANAWONGDON W,TONGTAWEE T,et a1.Precancerous gastric lesions with helicobacter pylori vacA+/babA2+/oipA+ genotype increase the risk of gastric cancer[J].BioMed Res Int,2020,2020:7243029.
[23] 韩少静,郭永泽,郑扬,等.内镜下胃癌活检组织中组织蛋白酶D和人类表皮生长因子受体2表达及意义[J].陕西医学杂志,2023,52(9):1249-1253.
[24] 常永欣,王鑫,唐照鹏.幽门螺杆菌感染对胃癌组织miR-146a表达及胃癌恶性进展的影响[J].实用癌症杂志,2022,37(3):392-395.
[25] 廖阳,鲁礼静,刘巧庆,等.HP感染致胃癌发病机制的研究进展[J].右江医学,2022,50(20):149-152.
[26] 钟爽,罗慧,施智兰,等.胆汁酸、幽门螺杆菌等因素诱导尾型同源盒转录因子2表达致胃黏膜肠上皮化生研究进展[J].陕西医学杂志,2023,52(6):771-774.
[27] SHIN K Y,JEON S W,CHO K B,et al.Clinical outcomes of the endoscopic submucosal dissection of early gastric cancer are comparable between absolute and new expanded criteria [J].Gut Liver,2015,9(2):181-187.
[28] PARK J S,RHA S Y,CHUNG H C,et al.Clinicopathological features and prognostic significance of HER2 expression in gastrie cancer[J].Oneology,2015,88(3):147-156.
[29] LAWNICZAK M,GAWIN A,JAROSZEWICZ-HEIGELMANN H,et al.Synchronous and metachronous neoplasms in gastric cancer patients:A 23-year study[J].Workd J Gastroenteral,2014,20(23):7480-7487.

相似文献/References:

[1]张 芬,石振旺,孙海兵.血清胃泌素17、胃蛋白酶原Ⅱ及血脂水平检测对结直肠腺瘤性息肉患者幽门螺杆菌Ⅱ型感染的诊断价值[J].陕西医学杂志,2024,(6):801.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.017]
　ZHANG Fen,SHI Zhenwang,SUN Haibing.Diagnostic value of G-17,PG Ⅱ and blood lipid levels in patients with colorectal adenomatous polyps for HP type Ⅱ infection[J].,2024,(9):801.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.017]

备注/Memo

备注/Memo:
基金项目:陕西省榆林市科技计划项目(YF-2020-060)
更新日期/Last Update: 2024-09-04